Tracked deals
4
4 tracked deals across 2019-2022.
Bellevue, Washington, United States
Ascensus Specialties produces specialty chemicals using world-class production plants in the US and UK, including sodium borohydride, reactive and alkali metals, boranes, CVD & ALD precursors, and other specialty chemicals. It also provides custom synthesis and related services to help customers make their products more efficiently and safely.
Tracked deals
4
4 tracked deals across 2019-2022.
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Addon
2 addon · 2 buyout
Last 3 years
Supporting Data
Ascensus Specialties LLC acquired the business and certain assets of Strem Chemicals UK (Strem UK), the independent UK distributor of Ascensus high‑purity research reagents and CVD/ALD precursors. The deal brings Strem UK’s customer relationships into Ascensus’ global distribution footprint, with Strem UK senior leadership remaining to support a smooth transition.
Ascensus Specialties LLC has acquired Wychem Limited, a UK-based independent fine chemical manufacturer, from AURELIUS Equity Opportunities. The acquisition expands Ascensus' European manufacturing footprint and adds Wychem's capabilities in aromatic compounds, halogenation and multi-step intermediates for pharmaceutical APIs; financial terms were not disclosed by Ascensus, while AURELIUS reported a 10.6x money-over-money multiple on the sale.
Ascensus Specialties LLC, a Wind Point Partners-backed specialty chemicals platform, has completed the acquisition of Strem Chemicals, a Newburyport, Massachusetts-based maker of high-purity research-grade catalysts, ligands, organometallics and CVD/ALD precursors. The deal brings Strem's custom synthesis and cGMP manufacturing capabilities into the Ascensus platform to expand lab-to-commercial scale offerings and accelerate R&D and product development.
Ascensus Specialties LLC, a Wind Point Partners–backed chemical producer, has signed a definitive agreement to acquire Callery, LLC, the global leader in boranes and specialty alcoholates. The add-on acquisition will combine complementary reagent chemistry capabilities to create a broader global reagents platform serving pharmaceutical, life sciences and specialty industrial end markets; terms were not disclosed.
Turn tracked acquisition activity into an outreach-ready buyer list.